Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000191:economics* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000779:Anesthetics, Local / Q000191:economics / Q000627:therapeutic use; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006302:Health Services Research; D006801:Humans; D007271:Injections, Intradermal / Q000191:economics / Q000706:statistics & numerical data; D008012:Lidocaine / Q000191:economics / Q000627:therapeutic use; D008875:Middle Aged; D009426:Netherlands; D019370:Observation; D026741:Physical Therapy Modalities / Q000191:economics* / Q000706:statistics & numerical data; D011320:Primary Health Care / Q000191:economics* / Q000379:methods; D013716:Tennis Elbow / Q000191:economics* / Q000628:therapy*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D008012:Lidocaine